A new concept for the treatment of cancer

Crystal structure of human MTH1 in complex with a key inhibitor.<br />Source: Stockholm University, Prof. Pal Stenmark.

Crystal structure of human MTH1 in complex with a key inhibitor.
Source: Stockholm University, Prof. Pal Stenmark.

A team of researchers from five Swedish universities has identified a new way to treat cancer. They present their concept in the journal „Nature“. It is based on inhibiting a specific enzyme called MTH1. Cancer cells, unlike normal cells, need MTH1 to survive. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in the cancer cells. The research group at Stockholm University has determined the structure of MTH1 based on diffraction measurements at HZB´s MX-beamline at BESSY II. These detailed structural studies are important for the development of efficient inhibitors targeting MTH1.

In recent decades, the development of new anticancer agents focused on targeting specific genetic defects in cancer cells. These often are effective initially, but later cause trouble due to emerging rapid resistance. In the current study, the researchers present a general enzymatic activity that all cancers tested rely on and that seems to be independent of the genetic changes found in specific cancers. The research team shows that all the investigated cancer tumours need the MTH1 enzyme to survive. In this respect, cancer cells differ from normal cells, which do not need this enzyme.

“The concept is built on the fact that cancer cells have an altered metabolism, resulting in oxidation of nucleotide building blocks,” says Thomas Helleday, professor at Karolinska Institutet, who leads the study: "MTH1 repairs the oxidized building blocks, preventing the oxidative stress from being incorporated into DNA and becoming DNA damage. This allows replication in cancer cells so they can divide and multiply. With an MTH1 inhibitor, the enzyme is blocked and damaged nucleotides enter DNA, causing damage and killing cancer cells."

Normal cells do not need MTH1 as they have regulated metabolism preventing damage of nucleotide building blocks. Finding a general enzymatic activity required only for cancer cells to survive opens up a whole new way of treating cancer.

Original publication:
“MTH1 inhibition kills cancer by preventing sanitation of the dNTP pool”, Helge Gad, Tobias Koolmeister, Ann-Sofie Jemth et al., Nature, online 2 April 2014, doi: 10.1038/nature13181. http://dx.doi.org/10.1038/nature13181.
“Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy”, Kilian V. M. Huber, Eidarus Salah, Branka Radic et al., Nature, online 2 April 2014, doi: 10.1038/nature13194. http://dx.doi.org/10.1038/nature13194

  • Copy link

You might also be interested in

  • Synchrotron radiation sources: toolboxes for quantum technologies
    Science Highlight
    01.12.2025
    Synchrotron radiation sources: toolboxes for quantum technologies
    Synchrotron radiation sources generate highly brilliant light pulses, ranging from infrared to hard X-rays, which can be used to gain deep insights into complex materials. An international team has now published an overview on synchrotron methods for the further development of quantum materials and technologies in the journal Advanced Functional Materials: Using concrete examples, they show how these unique tools can help to unlock the potential of quantum technologies such as quantum computing, overcome production barriers and pave the way for future breakthroughs.
  • Peat as a sustainable precursor for fuel cell catalyst materials
    Science Highlight
    25.11.2025
    Peat as a sustainable precursor for fuel cell catalyst materials
    Iron-nitrogen-carbon catalysts have the potential to replace the more expensive platinum catalysts currently used in fuel cells. This is shown by a study conducted by researchers from the Helmholtz-Zentrum Berlin (HZB), Physikalisch-Technische Bundesanstalt (PTB) and universities in Tartu and Tallinn, Estonia. At BESSY II, the team observed the formation of complex microstructures within various samples. They then analysed which structural parameters were particularly important for fostering the preferred electrochemical reactions. The raw material for such catalysts is well decomposed peat.
  • Helmholtz Investigator Group on magnons
    News
    24.11.2025
    Helmholtz Investigator Group on magnons
    Dr Hebatalla Elnaggar is setting up a new Helmholtz Investigator Group at HZB. At BESSY II, the materials scientist will investigate so-called magnons in magnetic perovskite thin films. The aim is to lay the foundations for future terahertz magnon technology: magnonic devices operating in the terahertz range could process data using a fraction of the energy required by the most advanced semiconductor devices, and at speeds up to a thousand times faster.